SEC Filings

Filing date	Description	Form	Filing Group	View
Apr 20, 2023	Definitive proxy statement relating to merger or acquisition	DEFM14A	Mergers & Acquisitions	0001104659-23-047840.pdf 0001104659-23-047840.rtf 0001104659-23-047840.xls View HTML
Feb 14, 2019	CT ORDER	CT ORDER	Other	9999999997-19-000307.pdf 9999999997-19-000307.rtf View HTML
Apr 24, 2020	CORRESP	CORRESP	Other	0001193125-20-119029.xls View HTML
Feb 11, 2019	CORRESP	CORRESP	Other	0001193125-19-033938.pdf 0001193125-19-033938.rtf View HTML
Jan 03, 2019	CORRESP	CORRESP	Other	0001193125-19-001382.pdf 0001193125-19-001382.rtf 0001193125-19-001382.xls View HTML
Feb 11, 2019	CORRESP	CORRESP	Other	0001193125-19-033950.pdf 0001193125-19-033950.rtf 0001193125-19-033950.xls View HTML
Feb 01, 2019	CORRESP	CORRESP	Other	0001193125-19-025794.pdf 0001193125-19-025794.rtf View HTML
Mar 29, 2019	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	0001750019-19-000009.pdf 0001750019-19-000009.rtf 0001750019-19-000009.xls View HTML
Mar 30, 2020	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	0001564590-20-013856.pdf 0001564590-20-013856.rtf 0001564590-20-013856.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Mar 16, 2021	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	0001564590-21-013563.pdf 0001564590-21-013563.rtf 0001564590-21-013563.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Adaptimmune